rs10994338
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000373827.6(ANK3):c.97-141731C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0796 in 151,914 control chromosomes in the GnomAD database, including 912 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.080 ( 912 hom., cov: 31)
Consequence
ANK3
ENST00000373827.6 intron
ENST00000373827.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.597
Publications
17 publications found
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.211 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ANK3 | ENST00000373827.6 | c.97-141731C>T | intron_variant | Intron 2 of 43 | 1 | ENSP00000362933.2 | ||||
| ANK3 | ENST00000503366.6 | c.64-141731C>T | intron_variant | Intron 1 of 43 | 2 | ENSP00000425236.1 | ||||
| ANK3 | ENST00000622427.4 | n.64-141731C>T | intron_variant | Intron 1 of 32 | 2 | ENSP00000483244.1 |
Frequencies
GnomAD3 genomes AF: 0.0796 AC: 12090AN: 151796Hom.: 907 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
12090
AN:
151796
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0796 AC: 12099AN: 151914Hom.: 912 Cov.: 31 AF XY: 0.0894 AC XY: 6638AN XY: 74228 show subpopulations
GnomAD4 genome
AF:
AC:
12099
AN:
151914
Hom.:
Cov.:
31
AF XY:
AC XY:
6638
AN XY:
74228
show subpopulations
African (AFR)
AF:
AC:
634
AN:
41466
American (AMR)
AF:
AC:
3005
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
AC:
155
AN:
3470
East Asian (EAS)
AF:
AC:
1144
AN:
5164
South Asian (SAS)
AF:
AC:
682
AN:
4810
European-Finnish (FIN)
AF:
AC:
1985
AN:
10542
Middle Eastern (MID)
AF:
AC:
11
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4332
AN:
67924
Other (OTH)
AF:
AC:
151
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
512
1024
1537
2049
2561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
672
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.